Safer and more effective blood thinners could be on the way following a groundbreaking discovery by researchers at UBC and the University of Michigan, published today in Nature Communications. By combining… Read More
PharmAla will be the initial supplier for clinical materials in a series of Psychedelic therapy clinics planned for opening by Incannex in Melbourne and across Australia VANCOUVER, BC — Globe… Read More
Program Seeks to Increase the Number of People Screened to Help Prevent Colorectal Cancer Diagnoses in Philadelphia LAVAL, QC — Bausch Health Companies Inc. (NYSE/TSX: BHC) and its gastroenterology business,… Read More
BEYFORTUS™ (nirsevimab) is the first and only single-dose immunization designed for the prevention of RSV disease in newborns and infants, including those born healthy, at term or preterm, or with… Read More
CALGARY, AB — Timeless Capital Corp. (“Timeless”) (TSXV: TLC.P) and Renaissance BioScience Corp. (“Renaissance”) are pleased to announce that they have entered into an amalgamation agreement dated April 5, 2023 (the… Read More
